IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 3 filers reported holding IMMUNOMEDICS INC in Q1 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $425,026,000 | +270.8% | 4,998,548 | +54.5% | 0.12% | +255.9% |
Q2 2020 | $114,632,000 | +691.4% | 3,234,537 | +201.0% | 0.03% | +580.0% |
Q1 2020 | $14,485,000 | -59.6% | 1,074,572 | -36.6% | 0.01% | -44.4% |
Q4 2019 | $35,866,000 | +179.7% | 1,694,965 | +75.3% | 0.01% | +125.0% |
Q3 2019 | $12,823,000 | -14.2% | 967,068 | -10.2% | 0.00% | 0.0% |
Q2 2019 | $14,939,000 | -32.2% | 1,077,034 | -6.2% | 0.00% | -42.9% |
Q1 2019 | $22,048,000 | +29.2% | 1,147,696 | -4.0% | 0.01% | +40.0% |
Q4 2018 | $17,063,000 | -11.1% | 1,195,695 | +29.8% | 0.01% | 0.0% |
Q3 2018 | $19,193,000 | -14.5% | 921,409 | -2.9% | 0.01% | -16.7% |
Q2 2018 | $22,457,000 | +116.2% | 948,751 | +33.4% | 0.01% | +200.0% |
Q1 2018 | $10,388,000 | -7.9% | 711,052 | +1.9% | 0.00% | 0.0% |
Q4 2017 | $11,274,000 | -12.4% | 697,637 | -24.3% | 0.00% | -33.3% |
Q3 2017 | $12,876,000 | +60.6% | 921,021 | +1.5% | 0.00% | +50.0% |
Q2 2017 | $8,015,000 | +197.0% | 907,623 | +117.6% | 0.00% | +100.0% |
Q1 2017 | $2,699,000 | +389.8% | 417,079 | +177.8% | 0.00% | – |
Q4 2016 | $551,000 | +56.1% | 150,126 | +38.4% | 0.00% | – |
Q3 2016 | $353,000 | -0.6% | 108,466 | -29.2% | 0.00% | – |
Q2 2016 | $355,000 | +102.9% | 153,178 | +118.9% | 0.00% | – |
Q1 2016 | $175,000 | -90.4% | 69,986 | -88.2% | 0.00% | – |
Q4 2015 | $1,815,000 | +109.1% | 591,309 | +17.1% | 0.00% | – |
Q3 2015 | $868,000 | -32.3% | 505,131 | +60.0% | 0.00% | – |
Q2 2015 | $1,283,000 | +34.9% | 315,794 | +27.3% | 0.00% | – |
Q1 2015 | $951,000 | +289.8% | 248,154 | +388.5% | 0.00% | – |
Q4 2014 | $244,000 | -26.3% | 50,795 | -42.9% | 0.00% | – |
Q3 2014 | $331,000 | +417.2% | 88,911 | +404.6% | 0.00% | – |
Q2 2014 | $64,000 | -80.1% | 17,619 | -76.9% | 0.00% | – |
Q1 2014 | $321,000 | -85.1% | 76,159 | -83.8% | 0.00% | -100.0% |
Q4 2013 | $2,160,000 | +1241.6% | 469,316 | +1709.0% | 0.00% | – |
Q3 2013 | $161,000 | -20.7% | 25,943 | -30.5% | 0.00% | – |
Q2 2013 | $203,000 | +217.2% | 37,341 | +71.5% | 0.00% | – |
Q4 2012 | $64,000 | -30.4% | 21,774 | -16.6% | 0.00% | – |
Q3 2012 | $92,000 | -33.3% | 26,107 | -32.8% | 0.00% | – |
Q2 2012 | $138,000 | +14.0% | 38,823 | +16.5% | 0.00% | – |
Q1 2012 | $121,000 | – | 33,331 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 4,750,000 | $112,433,000 | 20.02% |
Avoro Capital Advisors LLC | 17,714,461 | $419,301,000 | 16.14% |
Foresite Capital Management III, LLC | 2,541,729 | $60,163,000 | 12.96% |
Foresite Capital Management IV, LLC | 1,231,543 | $29,151,000 | 9.94% |
Ghost Tree Capital, LLC | 1,250,000 | $29,588,000 | 8.71% |
NEXTHERA CAPITAL LP | 1,329,104 | $31,460,000 | 4.87% |
RA Capital Management | 3,119,778 | $73,845,000 | 4.79% |
DLD Asset Management, LP | 2,682,100 | $63,458,000 | 4.78% |
Palo Alto Investors LP | 4,803,364 | $113,696,000 | 4.54% |
DLD Asset Management, LP | 2,411,600 | $57,058,000 | 4.30% |